Ad is loading...
CFJIX
Price
$36.18
Change
+$0.39 (+1.09%)
Updated
Nov 22 closing price
VVIAX
Price
$70.26
Change
+$0.54 (+0.77%)
Updated
Nov 22 closing price
Ad is loading...

CFJIX vs VVIAX

Header iconCFJIX vs VVIAX Comparison
Open Charts CFJIX vs VVIAXBanner chart's image
Calvert US Large Cap Value Rspnb Idx I
Price$36.18
Change+$0.39 (+1.09%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index Adm
Price$70.26
Change+$0.54 (+0.77%)
VolumeN/A
CapitalizationN/A
CFJIX vs VVIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CFJIX vs. VVIAX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CFJIX is a Buy and VVIAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 184B vs. CFJIX (1.82B). VVIAX pays higher dividends than CFJIX: VVIAX (2.36) vs CFJIX (1.91). CFJIX was incepted earlier than VVIAX: CFJIX (9 years) vs VVIAX (24 years). CFJIX is a more actively managed with annual turnover of: 31.00 vs. VVIAX (10.00). VVIAX has a lower initial minimum investment than CFJIX: VVIAX (3000) vs CFJIX (1000000). CFJIX annual gain was more profitable for investors over the last year : 30.86 vs. VVIAX (26.09). CFJIX return over 5 years is better than : 57.80 vs. VVIAX (53.09).
CFJIXVVIAXCFJIX / VVIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years24 years-
Gain YTD20.62719.672105%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets1.82B184B1%
Annual Yield % from dividends1.912.3681%
Returns for 1 year30.8626.09118%
Returns for 3 years15.0724.7761%
Returns for 5 years57.8053.09109%
Returns for 10 yearsN/A112.26-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOLE15.260.19
+1.26%
Dole plc
NCNO40.450.37
+0.92%
nCino
SGHT3.760.03
+0.80%
Sight Sciences
VICI32.370.25
+0.78%
VICI Properties
SABS3.070.01
+0.33%
SAB Biotherapeutics